Examining the effectiveness of antipsychotic medication in first-episode psychosis

被引：19
|
作者：
Taylor, Mark
Cavanagh, Jonathan [1 ]
Hodgson, Richard
Tiihonen, Jari [2 ,3 ]
机构：
[1] So Gen Hosp, Glasgow G51 4TF, Lanark, Scotland
[2] Univ Kuopio, Niuvanniemi Hosp, Dept Forens Psychiat, FIN-70211 Kuopio, Finland
[3] Natl Inst Hlth & Welf, Helsinki, Finland
来源：
JOURNAL OF PSYCHOPHARMACOLOGY | 2012年 / 26卷 / S5期
关键词：
Antipsychotic; effectiveness; first-episode psychosis; RANDOMIZED CONTROLLED-TRIAL; ATYPICAL ANTIPSYCHOTICS; 2ND-GENERATION ANTIPSYCHOTICS; SCHIZOAFFECTIVE DISORDER; CHRONIC-SCHIZOPHRENIA; DOUBLE-BLIND; DRUGS; OLANZAPINE; METAANALYSIS; RISPERIDONE;
D O I：
10.1177/0269881112439252
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
The regular use of antipsychotic medication is known to improve overall outcomes and diminish risk of relapse, but applying the results of randomised controlled trials (RCTs) into routine clinical practice is not always straightforward. Furthermore, psychiatrists, service users and policy makers can have trouble keeping up with the burgeoning and, at times, conflicting results from research trials, meta-analysis and systematic reviews. In this paper we examine the differences between efficacy and effectiveness trials with regard to antipsychotic medication with a focus on first-episode psychosis, after reviewing the relative contribution of antipsychotic medication to outcomes in schizophrenia.
引用
收藏
页码：27 / 32
页数：6
相关论文
共 50 条
  • [1] Prescribing pattern of antipsychotic medication for first-episode psychosis: a retrospective cohort study
    Keating, Dolores
    McWilliams, Stephen
    Boland, Fiona
    Doyle, Roisin
    Behan, Caragh
    Strawbridge, Judith
    Clarke, Mary
    BMJ OPEN, 2021, 11 (01):
  • [2] White Matter Changes Associated with Antipsychotic Treatment in First-Episode Psychosis
    Szeszko, Philip R.
    Robinson, Delbert G.
    Ikuta, Toshikazu
    Peters, Bart D.
    Gallego, Juan A.
    Kane, John
    Malhotra, Anil K.
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 (06) : 1324 - 1331
  • [3] Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?
    Ballesteros, Alejandro
    Sanchez-Torres, Ana M.
    Lopez-Ilundain, Jose M.
    Cabrera, Bibiana
    Lobo, Antonio
    Gonzalez-Pinto, Ana M.
    Diaz-Caneja, Covadonga
    Corripio, Iluminada
    Vieta, Eduard
    de la Serna, Elena
    Bobes, Julio
    Usall, Judith
    Contreras, Fernando
    Lorente-Omenaca, Ruth
    Mezquida, Gisela
    Bernardo, Miguel
    Cuesta, Manuel J.
    PSYCHOLOGICAL MEDICINE, 2018, 48 (13) : 2247 - 2256
  • [4] Childhood trauma, antipsychotic medication, and symptom remission in first-episode psychosis
    Ottesen, Akiah
    Hegelstad, W. T., V
    Joa, Inge
    Opjordsmoen, Stein E.
    Rund, Bjorn Rishovd
    Rossberg, Jan Ivar
    Simonsen, Erik
    Johannessen, Jan Olav
    Larsen, Tor K.
    Haahr, Ulrik Helt
    McGlashan, Thomas H.
    Friis, Svein
    Melle, Ingrid
    PSYCHOLOGICAL MEDICINE, 2023, 53 (06) : 2399 - 2408
  • [5] Non-adherence to antipsychotic medication in first-episode psychosis patients
    Hickling, Lauren M.
    Kouvaras, Stefanie
    Nterian, Zaklin
    Perez-Iglesias, Rocio
    PSYCHIATRY RESEARCH, 2018, 264 : 151 - 154
  • [6] An observational study of antipsychotic medication discontinuation in first-episode psychosis: clinical and functional outcomes
    Malla, Ashok
    Iyer, Srividya N.
    Joober, Ridha
    Rangaswamy, Thara
    Ramachandran, Padmavati
    Schmitz, Norbert
    Taksal, Aarati
    Mohan, Greeshma
    Margolese, Howard C.
    SOCIAL PSYCHIATRY AND PSYCHIATRIC EPIDEMIOLOGY, 2022, 57 (07) : 1329 - 1340
  • [7] Discontinuing Antipsychotic Medication After Remission from First-Episode Psychosis: A Survey of Psychiatrists' Attitudes in Taiwan
    Yen, Ko
    Liu, Chen-Chung
    Lin, Yi-Ting
    Chien, Yi-Ling
    Hsieh, Ming H.
    Liu, Chih-Min
    Hwang, Tzung-Jeng
    Liao, Wei-Hsiang
    Hwu, Hai-Gwo
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2022, 18 : 465 - 475
  • [8] A Comparison Study of Multiple Measures of Adherence to Antipsychotic Medication in First-Episode Psychosis
    Cassidy, Clifford M.
    Rabinovitch, Mark
    Schmitz, Norbert
    Joober, Ridha
    Malla, Ashok
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (01) : 64 - 67
  • [9] Immunomodulatory effects of antipsychotic treatment on gene expression in first-episode psychosis
    Mantere, Outi
    Trontti, Kalevi
    Garcia-Gonzalez, Judit
    Balcells, Ingrid
    Saarnio, Suvi
    Mantyla, Teemu
    Lindgren, Maija
    Kieseppa, Tuula
    Raij, Tuukka
    Honkanen, Jarno K.
    Vaarala, Outi
    Hovatta, Iiris
    Suvisaari, Jaana
    JOURNAL OF PSYCHIATRIC RESEARCH, 2019, 109 : 18 - 26
  • [10] Quality of life and functioning in first-episode psychosis Chinese patients with different antipsychotic medications
    Lee, Edwin H. M.
    Hui, Christy L. M.
    Lin, Jessie J. X.
    Ching, Elaine Y. N.
    Chang, W. C.
    Chan, Sherry K. W.
    Chen, Eric Y. H.
    EARLY INTERVENTION IN PSYCHIATRY, 2016, 10 (06) : 535 - 539
12345